WO2018177444A3 - 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用 - Google Patents

一种氮杂非那烯-3-酮的衍生物及其制备方法与应用 Download PDF

Info

Publication number
WO2018177444A3
WO2018177444A3 PCT/CN2018/088201 CN2018088201W WO2018177444A3 WO 2018177444 A3 WO2018177444 A3 WO 2018177444A3 CN 2018088201 W CN2018088201 W CN 2018088201W WO 2018177444 A3 WO2018177444 A3 WO 2018177444A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivative
azaphenalene
preparation
application
method therefor
Prior art date
Application number
PCT/CN2018/088201
Other languages
English (en)
French (fr)
Other versions
WO2018177444A2 (zh
Inventor
张�浩
王小东
徐卫良
徐炜政
Original Assignee
苏州康润医药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州康润医药有限公司 filed Critical 苏州康润医药有限公司
Priority to US16/497,773 priority Critical patent/US10669274B2/en
Publication of WO2018177444A2 publication Critical patent/WO2018177444A2/zh
Publication of WO2018177444A3 publication Critical patent/WO2018177444A3/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

一种氮杂非那烯-3-酮的衍生物及其制备方法与应用,属于药物合成技术领域。其结构如式(I)所示,其中R为氢,2-氟乙胺基,2,2,2-三氟乙胺基,二乙胺基,吡咯烷基,咪唑基,哌啶基,吗啡啉基,4-一甲氨基哌啶基,4-二甲氨基哌啶基,1-甲基-4-(甲氨基)哌啶基,1-苯基-4-甲氨基哌啶基,1-苄基-4-甲氨基哌啶基或者7-氟-1,2,3,4-四氢异喹啉基,本发明所述氮杂非那烯-3-酮衍生物制备过程简单,合成率高,后处理容易,并且纯度高,具有很高的抑制PARP酶的活性,为研发出活性更好的抗肿瘤药物提供基础,应用于PARP抑制剂。
PCT/CN2018/088201 2017-03-31 2018-05-24 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用 WO2018177444A2 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/497,773 US10669274B2 (en) 2017-03-31 2018-05-24 Azaphenalene-3-one derivative, preparation method therefor, and application therof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710205740.2A CN106883232B (zh) 2017-03-31 2017-03-31 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用
CN201710205740.2 2017-03-31

Publications (2)

Publication Number Publication Date
WO2018177444A2 WO2018177444A2 (zh) 2018-10-04
WO2018177444A3 true WO2018177444A3 (zh) 2018-11-22

Family

ID=59182652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/088201 WO2018177444A2 (zh) 2017-03-31 2018-05-24 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用

Country Status (3)

Country Link
US (1) US10669274B2 (zh)
CN (1) CN106883232B (zh)
WO (1) WO2018177444A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883232B (zh) * 2017-03-31 2019-01-22 苏州康润医药有限公司 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用
CN113527332B (zh) * 2020-04-13 2022-07-26 南开大学 具有生物活性的卡波特韦衍生物及其制备方法和应用
CN112851558B (zh) * 2021-02-05 2022-01-07 大连理工大学 2-氰基非那烯酮类化合物及其在白血病治疗中的应用
CN116253655A (zh) * 2023-03-10 2023-06-13 宁夏顺邦达新材料有限公司 一种合成邻氨基苯甲酸甲酯的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102341394A (zh) * 2009-01-23 2012-02-01 武田药品工业株式会社 聚(adp-核糖)聚合酶(parp)抑制剂
CN103703004A (zh) * 2011-12-31 2014-04-02 百济神州有限公司 作为parp抑制剂的稠合的四环或五环的二氢二氮杂*并咔唑酮
CN106083849A (zh) * 2011-12-31 2016-11-09 百济神州有限公司 作为parp抑制剂的稠合的四元或五元环吡啶并酞嗪酮类化合物
CN106883232A (zh) * 2017-03-31 2017-06-23 苏州康润医药有限公司 一种氮杂非那烯‑3‑酮的衍生物及其制备方法与应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102341394A (zh) * 2009-01-23 2012-02-01 武田药品工业株式会社 聚(adp-核糖)聚合酶(parp)抑制剂
CN103703004A (zh) * 2011-12-31 2014-04-02 百济神州有限公司 作为parp抑制剂的稠合的四环或五环的二氢二氮杂*并咔唑酮
CN106083849A (zh) * 2011-12-31 2016-11-09 百济神州有限公司 作为parp抑制剂的稠合的四元或五元环吡啶并酞嗪酮类化合物
CN106883232A (zh) * 2017-03-31 2017-06-23 苏州康润医药有限公司 一种氮杂非那烯‑3‑酮的衍生物及其制备方法与应用

Also Published As

Publication number Publication date
US10669274B2 (en) 2020-06-02
US20200031828A1 (en) 2020-01-30
WO2018177444A2 (zh) 2018-10-04
CN106883232B (zh) 2019-01-22
CN106883232A (zh) 2017-06-23

Similar Documents

Publication Publication Date Title
WO2018177444A3 (zh) 一种氮杂非那烯-3-酮的衍生物及其制备方法与应用
CA3082011A1 (en) Methods of using substituted pyrazole and pyrrole compounds and for treatment of hyperproliferative diseases
MX2012014017A (es) Derivados de heteroaril imidazolona como inhibidores de jak.
MX2012007175A (es) Derivados de imidazopiridina como inhibidores de jak.
NZ702574A (en) Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors
IL172942A0 (en) Pyrazoloisoquinoline derivatives as kinase inhibitors
GEP20166484B (en) Protein kinase inhibitors
TN2014000042A1 (en) Cyclopropaneamine compound
NO20082511L (no) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
MX2019000536A (es) Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
HK1136827A1 (en) Spirocyclic cyclohexane derivatives
MX2012002876A (es) Derivados de dihidropteridinona, proceso para su preparacion y uso farmaceutico.
AU2009306733C1 (en) Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
GEP20156346B (en) Imidazole derivatives as pde10a enzyme inhibitors
NO20090251L (no) Camptotecinderivater med antitumoraktivitet
SG10201805267UA (en) Piperazine derivatives having multimodal activity against pain
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
NZ756854A (en) Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
NZ719028A (en) N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
NZ592429A (en) PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
EP4070794A3 (en) Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
UA94054C2 (en) Nitrocatechol derivatives as comt inhibitors
NO20053673L (no) Nye antikonvulsanderivatsalter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18777439

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2018777439

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2018777439

Country of ref document: EP

Effective date: 20191031

122 Ep: pct application non-entry in european phase

Ref document number: 18777439

Country of ref document: EP

Kind code of ref document: A2